Raffaele Costanzo

1.4k total citations
53 papers, 899 citations indexed

About

Raffaele Costanzo is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Raffaele Costanzo has authored 53 papers receiving a total of 899 indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Oncology, 29 papers in Pulmonary and Respiratory Medicine and 12 papers in Molecular Biology. Recurrent topics in Raffaele Costanzo's work include Lung Cancer Treatments and Mutations (23 papers), Lung Cancer Research Studies (21 papers) and Colorectal Cancer Treatments and Studies (10 papers). Raffaele Costanzo is often cited by papers focused on Lung Cancer Treatments and Mutations (23 papers), Lung Cancer Research Studies (21 papers) and Colorectal Cancer Treatments and Studies (10 papers). Raffaele Costanzo collaborates with scholars based in Italy, Malaysia and United States. Raffaele Costanzo's co-authors include Alessandro Morabito, Nicola Normanno, Agnese Montanino, Claudia Sandomenico, Maria Carmela Piccirillo, Gaetano Rocco, Guido Carillio, Francesco Perrone, Gennaro Daniele and Anna Manzo and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Scientific Reports.

In The Last Decade

Raffaele Costanzo

49 papers receiving 882 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Raffaele Costanzo Italy 16 563 368 277 194 147 53 899
Paolo De Giuli Italy 15 454 0.8× 384 1.0× 331 1.2× 115 0.6× 137 0.9× 19 1.2k
Claudia Sandomenico Italy 18 562 1.0× 366 1.0× 404 1.5× 132 0.7× 124 0.8× 52 987
Fernando C. Santini United States 13 685 1.2× 464 1.3× 211 0.8× 73 0.4× 143 1.0× 34 958
Guido Carillio Italy 16 396 0.7× 265 0.7× 221 0.8× 122 0.6× 159 1.1× 47 772
Ferdinando Riccardi Italy 18 602 1.1× 296 0.8× 190 0.7× 283 1.5× 122 0.8× 77 875
Guoshuang Shen China 14 538 1.0× 356 1.0× 298 1.1× 83 0.4× 219 1.5× 61 1000
Yuichi Sakamori Japan 19 1.0k 1.8× 932 2.5× 330 1.2× 127 0.7× 146 1.0× 81 1.5k
Lisa Rodríguez United States 12 615 1.1× 318 0.9× 287 1.0× 112 0.6× 250 1.7× 20 1.1k
Adrian Langleben Canada 17 725 1.3× 416 1.1× 316 1.1× 167 0.9× 158 1.1× 55 1.1k
Yuankai Shi China 14 547 1.0× 395 1.1× 276 1.0× 123 0.6× 104 0.7× 101 997

Countries citing papers authored by Raffaele Costanzo

Since Specialization
Citations

This map shows the geographic impact of Raffaele Costanzo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Raffaele Costanzo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Raffaele Costanzo more than expected).

Fields of papers citing papers by Raffaele Costanzo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Raffaele Costanzo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Raffaele Costanzo. The network helps show where Raffaele Costanzo may publish in the future.

Co-authorship network of co-authors of Raffaele Costanzo

This figure shows the co-authorship network connecting the top 25 collaborators of Raffaele Costanzo. A scholar is included among the top collaborators of Raffaele Costanzo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Raffaele Costanzo. Raffaele Costanzo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Costanzo, Raffaele, et al.. (2026). Aerothermodynamic response of ZrB2-based compositionally complex ultra-high-temperature ceramics in hypersonic and supersonic flow conditions. Journal of the European Ceramic Society. 46(8). 118184–118184.
2.
Costanzo, Raffaele, Anna M. Borghi, Andrea Mattera, et al.. (2025). An experimental and computational investigation of executive functions and inner speech in schizophrenia spectrum disorders. Scientific Reports. 15(1). 5185–5185. 1 indexed citations
3.
Costanzo, Raffaele, et al.. (2024). Does EFSA statement on Monacolin content of nutraceutical combinations impair their lipid lowering effect? The LopiGLIK experience. SHILAP Revista de lepidopterología. 10(1). 38–38. 1 indexed citations
4.
Montanino, Agnese, Anna Manzo, Guido Carillio, et al.. (2021). Angiogenesis Inhibitors in Small Cell Lung Cancer. Frontiers in Oncology. 11. 655316–655316. 53 indexed citations
5.
Morabito, Alessandro, Gennaro Daniele, Raffaele Costanzo, et al.. (2017). A multicenter, randomized, phase 3 trial comparing fixed dose versus toxicity-adjusted dose of cisplatin + etoposide in extensive small-cell lung cancer (SCLC) patients. Lung Cancer. 108. 15–21. 7 indexed citations
6.
Manzo, Anna, Guido Carillio, Agnese Montanino, et al.. (2016). Focus on Nintedanib in NSCLC and Other Tumors. Frontiers in Medicine. 3. 68–68. 12 indexed citations
7.
Cavalcanti, Ernesta, Monica Cantile, Sabrina Chiara Cecere, et al.. (2016). Correlation of Serum Cystatin C with Glomerular Filtration Rate in Patients Receiving Platinum-Based Chemotherapy. Analytical Cellular Pathology. 2016. 1–5. 8 indexed citations
8.
Maïo, Massimo Di, Alessandro Morabito, Maria Carmela Piccirillo, et al.. (2014). Combining Anti-Epidermal Growth Factor Receptor (EGFR) and Anti-Angiogenic Strategies in Advanced NSCLC: We Should have Known Better…. Current Pharmaceutical Design. 20(24). 3901–3913. 4 indexed citations
9.
Morabito, Alessandro, Raffaele Costanzo, Anna Maria Rachiglio, et al.. (2013). Activity of Gefitinib in a Non–Small-Cell Lung Cancer Patient with Both Activating and Resistance EGFR Mutations. Journal of Thoracic Oncology. 8(7). e59–e60. 14 indexed citations
10.
Losito, Simona, Cono Scaffa, Monica Cantile, et al.. (2013). Lung cancer diagnosis on ovary mass: a case report. Journal of Ovarian Research. 6(1). 34–34. 14 indexed citations
11.
12.
Morabito, Alessandro, Claudia Sandomenico, Raffaele Costanzo, et al.. (2012). Positron Emission Tomography and Circulating Tumor Cells to Monitor a Dramatic Response to Gefitinib. Journal of Thoracic Oncology. 7(11). e27–e28. 8 indexed citations
13.
Sandomenico, Claudia, Raffaele Costanzo, Guido Carillio, et al.. (2012). Bevacizumab in Non Small Cell Lung Cancer: Development, Current Status and Issues. Current Medicinal Chemistry. 19(7). 961–971. 13 indexed citations
14.
Gridelli, Cesare, Antônio Rossi, Roberto Bianco, et al.. (2012). Treatment of pulmonary neuroendocrine tumours: State of the art and future developments. Cancer Treatment Reviews. 39(5). 466–472. 51 indexed citations
15.
Morabito, Alessandro, Maria Carmela Piccirillo, Raffaele Costanzo, et al.. (2010). Vandetanib: An overview of its clinical development in NSCLC andother tumors. Drugs of today. 46(9). 683–683. 36 indexed citations
16.
Caraglia, Michele, Raffaele Addeo, Raffaele Costanzo, et al.. (2005). Phase II study of temozolomide plus pegylated liposomal doxorubicin in the treatment of brain metastases from solid tumours. Cancer Chemotherapy and Pharmacology. 57(1). 34–39. 51 indexed citations
17.
Placido, Sabino De, Michelino De Laurentiis, M. De Lena, et al.. (2005). A randomised factorial trial of sequential doxorubicin and CMF vs CMF and chemotherapy alone vs chemotherapy followed by goserelin plus tamoxifen as adjuvant treatment of node-positive breast cancer. British Journal of Cancer. 92(3). 467–474. 24 indexed citations
18.
19.
Pignata, Sandro, Elisa Varriale, F. Iodice, et al.. (2000). A phase I study of gemcitabine and epirubicin for the treatment of platinum-resistant or refractory advanced ovarian cancer. Annals of Oncology. 11(5). 613–616. 11 indexed citations
20.
Placido, Sabino De, Rossella Lauria, Francesco Perrone, et al.. (2000). Vinorelbine + Mitomycin C as Second-Line Treatment of Metastatic Breast Cancer: A Two-Stage Phase 2 Study. Oncology. 58(1). 8–14. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Paolo De Giuli Breakdown of academic impact, for papers by Claudia Sandomenico Breakdown of academic impact, for papers by Fernando C. Santini Breakdown of academic impact, for papers by Guido Carillio Breakdown of academic impact, for papers by Ferdinando Riccardi Breakdown of academic impact, for papers by Guoshuang Shen Breakdown of academic impact, for papers by Yuichi Sakamori Breakdown of academic impact, for papers by Lisa Rodríguez Breakdown of academic impact, for papers by Adrian Langleben Breakdown of academic impact, for papers by Yuankai Shi
Rankless by CCL
2026